Whose vaccine helped prevent Haemophilus influenzae type b disease in children?

Quick Answer

The Hib vaccine was developed through work by several scientists, including John Robbins and Rachel Schneerson, and it became widely used in the late 1980s. It sharply reduced cases of bacterial meningitis and epiglottitis in children.

The Full Story

The Haemophilus influenzae type b, or Hib, vaccine was a major pediatric breakthrough. Key contributors included John Robbins and Rachel Schneerson at the U.S. National Institutes of Health, who helped develop the conjugate vaccine approach that made the shot effective in infants. The vaccine became widely adopted in the late 1980s and early 1990s. It dramatically reduced invasive Hib disease, including meningitis and epiglottitis, in countries that used it routinely.

Key Facts

1.Late 1980s: Hib vaccine became widely used

2.Protected against a major cause of pediatric meningitis

3.Conjugate vaccine design made infant protection possible

YouTube Angle

Was this answer helpful?

Tap a reaction — it helps us pick what to cover next.